Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas

Magn Reson Imaging. 2023 Oct:102:96-102. doi: 10.1016/j.mri.2023.05.004. Epub 2023 May 10.

Abstract

Purpose: To evaluate the clinical utility of amide proton transfer-weighted imaging (APTw) and arterial spin labeling (ASL) in differentiating solitary brain metastases (SBMs) from glioblastomas (GBMs).

Methods: Forty-eight patients diagnosed with brain tumors were enrolled. All patients underwent conventional MRI, APTw, and ASL scans on a 3.0 T MRI system. The mean APTw value and mean cerebral blood flow (CBF) value were measured. The differences in various parameters between GBMs and SBMs were assessed using the independent-samples t-test. The quantitative performance of these MRI parameters in distinguishing between GBMs and SBMs was evaluated using receiver operating characteristic (ROC) curve analysis.

Results: GBMs exhibited significantly higher APTw and CBF values in peritumoral regions compared with SBMs (P < 0.05). There was no significant difference between SBMs and GBMs in tumor cores. APTw MRI had a higher diagnostic efficiency in differentiating SBMs from GBMs (area under the curve [AUC]: 0.864; 75.0% sensitivity and 81.8% specificity). Combined use of APTw and CBF value increased the AUC to 0.927.

Conclusion: APTw may be superior to ASL for distinguishing between SBMs and GBMs. Combination of APTw and ASL showed better discrimination and a superior diagnostic performance.

Keywords: APTw; ASL; Glioblastoma; Magnetic resonance imaging; Metastases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides
  • Brain Neoplasms* / pathology
  • Glioblastoma* / diagnostic imaging
  • Glioblastoma* / pathology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Protons
  • Spin Labels

Substances

  • Protons
  • Amides
  • Spin Labels